Current analytical methods used in the in vitro evaluation of nano-drug delivery systems

Current Pharmaceutical Analysis

Volumn 5, Issue 4, 2009, Pages 358-366

  Nagvekar, Ankita A ^a   Trickler, William J ^a   Dash, Alekha K ^a  

^a CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cellular uptake; Cytotoxicity assay; In vitro characterization; In vitro release; Nanoparticulate drug delivery systems; Size and surface charge

Indexed keywords

NANOPARTICLE; PEPTIDE DERIVATIVE; PROTEIN DERIVATIVE;

CELL CULTURE; CELL TRANSPORT; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG TARGETING; DRUG TRANSPORT; DRUG UPTAKE; ENCAPSULATION; FLOW CYTOMETRY; HUMAN; IN VITRO STUDY; INFRARED SPECTROSCOPY; MICROSCOPY; NANOPHARMACEUTICS; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; REVIEW; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; ZETA POTENTIAL;

EID: 75149149486     PISSN: 15734129     EISSN: None     Source Type: Journal    
DOI: 10.2174/157341209789649122     Document Type: Review

References (64)

1. Okada, H.; Doken, Y.; Ogawa, Y.; Toguchi, H. Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers. Pharm. Res., 1994, 11, 1143-1147.
2. Nihant, N.; Schugens, C.; Grandfils, C.; Jerome, R.; Teyssie, P. Polylactide microparticles prepared by double emulsion/ evaporation technique. I. Effect of primary emulsion stability. Pharm. Res., 1994, 11, 1479-1484.
3. Roy, K.; Mao, H.Q.; Huang, S.K.; Leong, K.W. Oral gene delivery with chitosan - DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat. Med., 1999, 5, 387-391.
4. Li, M.G.; Lu, W.L.; Wang, J.C.; Zhang, X.; Zhang, H.; Wang, X.Q.; Wu, C.S.; Zhang, Q. Preparation and characterization of insulin nanoparticles employing chitosan and poly(methylmethacrylate/ methylmethacrylic acid) copolymer. J. Nanosci. Nanotechnol., 2006, 6, 2874-2886.
5. Zillies, J.; Coester, C. Evaluating gelatin based nanoparticles as a carrier system for double stranded oligonucleotides. J. Pharm. Pharm. Sci., 2005, 7, 17-21.
6. Wang, D.; Robinson, D.R.; Kwon, G.S.; Samuel, J. Encapsulation of plasmid DNA in biodegradable poly(D, L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery. J. Control. Release, 1999, 57, 9-18.
7. Luo, D.; Woodrow-Mumford, K.; Belcheva, N.; Saltzman, W.M. Controlled DNA delivery systems. Pharm. Res., 1999, 16, 1300-1308.
8. Zambaux, M.F.; Bonneaux, F.; Gref, R.; Dellacherie, E.; Vigneron, C. Preparation and characterization of protein C-loaded PLA nanoparticles. J. Control Release, 1999, 60, 179-188.
9. Yeh, M.K.; Tung, S.M.; Lu, D.W.; Chen, J.L.; Chiang, C.H. Formulation factors for preparing ocular biodegradable delivery system of 5-fluorouracil microparticles J. Microencapsul., 2001, 18, 507-519.
10. Jeh, H.S.; Lu, S.; George, S.C. Encapsulation of PROLI/NO in biodegradable microparticles. J. Microencapsul., 2004, 21, 3-13.
11. Jaiswal, J.; Gupta, S.K.; Kreuter, J. Preparation of biodegradable cyclosporine nanoparticles by high-pressure emulsification-solvent evaporation process. J. Control. Release, 2004, 96, 169-178.
12. Pamujula, S.; Graves, R.A.; Freeman, T.; Srinivasan, V.; Bostanian, L. A.; Kishore, V.; Mandal, T. K.; Oral delivery of spray dried PLGA/amifostine nanoparticles. J. Pharm. Pharmacol., 2004, 56, 1119-1125.
13. Kreuter, J.; Drug targeting with nanoparticles. Eur. J. Drug Metab. Pharmacokinet., 1994, 19, 253-256.
14. Mao, S.J.; Hou, S.X.; He, R.; Zhang, L.K.; Wei, D.P.; Bi, Y.Q.; Jin, H. Uptake of albumin nanoparticle surface modified with glycyrrhizin by primary cultured rat hepatocytes. World J. Gastroenterol., 2005, 11, 3075-3079.
15. Hillyer, J.F.; Albrecht, R.M. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J. Pharm. Sci., 2001, 90, 1927-1936.
16. Lamprecht, A.; Bouligand, Y.; Benoit, J. P. New lipid nanocapsules exhibit sustained release properties for amiodarone. J. Control. Release, 2002, 84, 59-68.
17. Jeong, Y.I.; Cheon, J.B.; Kim, S.H.; Nah, J.W.; Lee, Y.M.; Sung, Y.K.; Akaike, T.; Cho, C.S. Clonazepam release from core-shell type nanoparticles in vitro. J. Control. Release, 1998, 51, 169-178.
18. Verma, A.K.; Sachin, K.; Saxena, A.; Bohidar, H.B. Release kinetics from bio-polymeric nanoparticles encapsulating protein synthesis inhibitor- cycloheximide, for possible therapeutic applications. Curr. Pharm. Biotechnol., 2005, 6, 121-130.
19. Yegin, B.A.; Lamprecht, A. Lipid nanocapsule size analysis by hydrodynamic chromatography and photon correlation spectroscopy. Int. J. Pharm., 2006, 320, 165-170.
20. Williams, A.; Varela, E.; Meehan, E.; Tribe, K. Characterisation of nanoparticulate systems by hydrodynamic chromatography. Int. J. Pharm., 2002, 242, 295-299.
21. Brown, P.H.; Schuck, P. Macromolecular size-and-shape distributions by sedimentation velocity analytical ultracentrifugation. Biophys. J., 2006, 90, 4651-4661.
22. Vogel, V.; Langer, K.; Balthasar, S.; Schuck, P.; Machtle, W.; Hasse, W.; Tziatzios, C.; Broek, J. A.; Schubert, D. Characterization of serum albumin nanoparticles by sedimentation velocity analysis and electron microscopy. Prog. Colloid. Polym. Sci., 2002, 119, 31-36.
23. Contado, C.; Bregola, L.; Dondi, F. Sedimentation field flow fractionation of immunoglobulin A coated polystyrene beads. Influence of carrier composition on complex characterization. J. Chromatogr. A, 2007, 1169, 158-174.
24. Layre, A.M.; Couvreur, P.; Richard, J.; Requier, D.; Eddine Ghermani, N.; Gref, R. Freeze-drying of composite core-shell nanoparticles. Drug Dev. Ind. Pharm., 2006, 32, 839-846.
25. Yang, S.C.; Zhu, J.B. Preparation and characterization of camptothecin solid lipid nanoparticles. Drug Dev. Ind. Pharm., 2002, 28, 265-274.
26. Cavalli, R.; Peira, E.; Caputo, O.; Gasco, M.R. Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with beta-cyclodextrins. Int. J. Pharm., 1999, 182, 59-69.
27. Ma, X.; Jian, R.; Chang, P.R.; Yu, J. Fabrication and characterization of citric acid-modified starch nanoparticles/plasticized-starch composites. Biomacromolecules, 2008, 9, 3314-3320.
28. Beck, R.C.; Pohlmann, A.R.; Hoffmeister, C.; Gallas, M.R.; Collnot, E.; Schaefer, U.F.; Guterres, S.S.; Lehr, C.M. Dexamethasoneloaded nanoparticle-coated microparticles: correlation between in vitro drug release and drug transport across Caco-2 cell monolayers. Eur. J. Pharm. Biopharm., 2007, 67, 18-30.
29. Pan, J.; Wang, Y.; Feng, S.S. Formulation, characterization, and in vitro evaluation of quantum dots loaded in poly(lactide)-vitamin E TPGS nanoparticles for cellular and molecular imaging. Biotechnol. Bioeng., 2008, 101, 622-633.
30. Prabu, P.; Chaudhari, A.A.; Aryal, S.; Dharmaraj, N.; Park, S.Y.; Kim, W.D.; Kim, H.Y. In vitro evaluation of poly(caporlactone) grafted dextran (PGD) nanoparticles with cancer cell. J. Mater. Sci. Mater Med., 2008, 19, 2157-2163.
31. Takeuchi, H.; Yamamoto, H.; Niwa, T.; Hino, T.; Kawashima, Y. Mucoadhesion of polymer-coated liposomes to rat intestine in vitro. Chem. Pharm. Bull (Tokyo), 1994, 42, 1954-1956.
32. El-Shabouri, M.H. Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A. Int. J. Pharm., 2002, 249, 101-108.
33. Calvo, P.; Vila-Jato, J.L.; Alonso, M.J. Effect of lysozyme on the stability of polyester nanocapsules and nanoparticles: stabilization approaches. Biomaterials, 1997, 18, 1305-1310.
34. Ferdous, A.J.; Stembridge, N.Y.; Singh, M. Role of monensin PLGA polymer nanoparticles and liposomes as potentiator of ricin A immunotoxins in vitro. J. Control. Release, 1998, 50, 71-78.
35. Stolnik, S.; Dunn, S.E.; Garnett, M.C.; Davies, M.C.; Coombes, A.G.; Taylor, D.C.; Irving, M.P.; Purkiss, S.C.; Tadros, T.F.; Davis, S.S.; et al.; Surface modification of poly(lactide-coglycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers. Pharm. Res., 1994, 11, 1800-1808.
36. Panyam, J.; Zhou, W.Z.; Prabha, S.; Sahoo, S.K.; Labhasetwar, V. Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J., 2002, 16, 1217-1226.
37. Tobio, M.; Gref, R.; Sanchez, A.; Langer, R.; Alonso, M.J. Stealth PLA-PEG nanoparticles as protein carriers for nasal administration. Pharm. Res., 1998, 15, 270-275.
38. Redhead, H.M.; Davis, S.S.; Illum, L. Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation. J. Control. Release, 2001, 70, 353-363.
39. Sahoo, S. K.; Panyam, J.; Prabha, S.; Labhasetwar, V.; Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J. Control. Release., 2002, 82, 105-114.
40. Langer, K.; Balthasar, S.; Vogel, V.; Dinauer, N.; von Briesen, H.; Schubert, D. Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int. J. Pharm., 2003, 257, 169-180.
41. Felgner, P.L.; Barenholz, Y.; Behr, J.P.; Cheng, S.H.; Cullis, P.; Huang, L.; Jessee, J.A.; Seymour, L.; Szoka, F.; Thierry, A.R.; Wagner, E.; Wu, G. Nomenclature for synthetic gene delivery systems. Hum. Gene. Ther., 1997, 8, 511-512.
42. De Smedt, S.C.; Demeester, J.; Hennink, W.E. Cationic polymer based gene delivery systems. Pharm. Res., 2000, 17, 113-26.
43. Arnedo, A.; Espuelas, S.; Irache, J.M. Albumin nanoparticles as carriers for a phosphodiester oligonucleotide. Int. J. Pharm., 2002, 244, 59-72.
44. Fischer, D.; Li, Y.; Ahlemeyer, B.; Krieglstein, J.; Kissel, T. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials, 2003, 24, 1121-1131.
45. Dash, A.K. Determination of the physical state of drug in microcapsule and microsphere formulations. J. Microencapsul., 1997, 14, 101-112.
46. Molpeceres, J.; Aberturas, M.R.; Guzman, M. Biodegradable nanoparticles as a delivery system for cyclosporine: preparation and characterization. J. Microencapsul., 2000, 17, 599-614.
47. Le Corre, P.; Rytting, J.H.; Gajan, V.; Chevanne, F.; Le Verge, R. In vitro controlled release kinetics of local anaesthetics from poly(D,L-lactide) and poly(lactide-co-glycolide) microspheres. J. Microencapsul., 1997, 14, 243-255.
48. Panyam, J.; Williams, D.; Dash, A.; Leslie-Pelecky, D.; Labhasetwar, V. Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles. J. Pharm. Sci., 2004, 93, 1804-1814.
49. Sarmento, B.; Ribeiro, A.J.; Veiga, F.; Ferreira, D.C.; Neufeld, R.J. Insulin-loaded nanoparticles are prepared by alginate ionotropic pre-gelation followed by chitosan polyelectrolyte complexation. J. Nanosci. Nanotechnol., 2007, 7, 2833-2841.
50. Sarmento, B.; Ribeiro, A.; Veiga, F.; Sampaio, P.; Neufeld, R.; Ferreira, D. Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm. Res., 2007, 24, 2198-2206.
51. Kouassi, G.K.; Irudayaraj, J. A nanoparticle-based immobilization assay for prion-kinetics study. J. Nanobiotechnology, 2006, 4, 8.
52. Dablemont, C.; Lang, P.; Mangeney, C.; Piquemal, J.Y.; Petkov, V.; Herbst, F.; Viau, G. FTIR and XPS study of Pt nanoparticle functionalization and interaction with alumina. Langmuir, 2008, 24, 5832-5841.
53. Panyam, J.; Labhasetwar, V.; Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles. Mol. Pharm., 2004, 1, 77-84.
54. Gomes, A.J.; Faustino, A.S.; Lunardi, C.N.; Lunardi, L.O.; Machado, A.E. Evaluation of nanoparticles loaded with benzopsoralen in rat peritoneal exudate cells. Int. J. Pharm., 2007, 332, 153-160.
55. Leo, E.; Brina, B.; Forni, F.; Vandelli, M.A. In vitro evaluation of PLA nanoparticles containing a lipophilic drug in water-soluble or insoluble form. Int. J. Pharm., 2004, 278, 133-141.
56. Emami, J.; Hamishehkar, H.; Najafabadi, A.R.; Gilani, K.; Minaiyan, M.; Mahdavi, H.; Nokhodchi, A. A novel approach to prepare insulin-loaded poly(lactic-co-glycolic acid) microcapsules and the protein stability study. J. Pharm. Sci., 2009, 98, 1712-31.
57. Halder, A.; Maiti, S.; Sa, B. Entrapment efficiency and release characteristics of polyethyleneimine-treated or -untreated calcium alginate beads loaded with propranolol-resin complex. Int. J. Pharm., 2005, 302, 84-94.
58. Umamaheswari, A.; Venkateswarlu, K. Impact of nitrophenols on the photosynthetic electron transport chain and ATP content in Nostoc muscorum and Chlorella vulgaris. Ecotoxicol. Environ. Saf., 2004, 58, 256-259.
59. Panyam, J.; Labhasetwar, V. Targeting intracellular targets. Curr. Drug Deliv., 2004, 1, 235-247.
60. Trickler, W.J.; Nagvekar, A.A.; Dash, A.K. A novel nanoparticle formulation for sustained paclitaxel delivery. AAPS PharmSciTech, 2008, 9, 486-493.
61. Chavanpatil, M.D.; Khdair, A.; Panyam, J. Surfactant-polymer nanoparticles: a novel platform for sustained and enhanced cellular delivery of water-soluble molecules. Pharm. Res., 2007, 24, 803-810.
62. Wong, H.L.; Bendayan, R.; Rauth, A.M.; Xue, H.Y.; Babakhanian, K.; Wu, X.Y. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system. J. Pharmacol. Exp. Ther., 2006, 317, 1372-1381.
63. Chavanpatil, M.D.; Patil, Y.; Panyam, J. Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux. Int. J. Pharm., 2006, 320, 150-156.
64. Panyam, J.; Sahoo, S.K.; Prabha, S.; Bargar, T.; Labhasetwar, V. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles. Int. J. Pharm., 2003, 262, 1-11.